Shopping Cart
- Remove All
- Your shopping cart is currently empty
SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $715 | 6-8 weeks | |
50 mg | $929 | 6-8 weeks | |
100 mg | $1,490 | 6-8 weeks |
Description | SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours. |
Molecular Weight | 424.5 |
Formula | C25H24N6O |
Cas No. | 2713577-16-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.